Found: 43
Select item for more details and to access through your institution.
Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP).
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 11, p. 1051, doi. 10.1177/02698811231182607
- By:
- Publication type:
- Article
Clinical correlates of early onset antipsychotic treatment resistance.
- Published in:
- Journal of Psychopharmacology, 2022, v. 36, n. 11, p. 1226, doi. 10.1177/02698811221132537
- By:
- Publication type:
- Article
A predictor model of treatment resistance in schizophrenia using data from electronic health records.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0274864
- By:
- Publication type:
- Article
Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine.
- Published in:
- Journal of Psychopharmacology, 2022, v. 36, n. 4, p. 498, doi. 10.1177/02698811221078746
- By:
- Publication type:
- Article
Transdiagnostic individualized clinically-based risk calculator for the automatic detection of individuals at-risk and the prediction of psychosis: external replication in 2,430,333 US patients.
- Published in:
- Translational Psychiatry, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41398-020-01032-9
- By:
- Publication type:
- Article
A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data.
- Published in:
- Translational Psychiatry, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41398-020-00962-8
- By:
- Publication type:
- Article
A MACHINE LEARNING FRAMEWORK FOR ROBUST AND RELIABLE PREDICTION OF SHORT- AND LONG-TERM CLINICAL RESPONSE IN INITIALLY ANTIPSYCHOTICNAÏVE SCHIZOPHRENIA PATIENTS BASED ON MULTIMODAL NEUROPSYCHIATRIC DATA.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S34, doi. 10.1093/schbul/sbaa031.078
- By:
- Publication type:
- Article
The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS).
- Published in:
- Frontiers in Psychiatry, 2019, p. N.PAG, doi. 10.3389/fpsyt.2018.00757
- By:
- Publication type:
- Article
Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects.
- Published in:
- Psychopharmacology, 2018, v. 235, n. 7, p. 1875, doi. 10.1007/s00213-018-4877-9
- By:
- Publication type:
- Article
Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia.
- Published in:
- Journal of Personalized Medicine, 2016, v. 6, n. 1, p. 9, doi. 10.3390/jpm6010009
- By:
- Publication type:
- Article
Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium.
- Published in:
- Innovations in Clinical Neuroscience, 2015, v. 12, p. 5S
- By:
- Publication type:
- Article
Lessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM Section on Designing the Right Series of Experiments.
- Published in:
- Innovations in Clinical Neuroscience, 2015, v. 12, p. 11S
- By:
- Publication type:
- Article
A double-bind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2014, v. 14, n. 1, p. 1, doi. 10.1186/s12888-014-0351-3
- By:
- Publication type:
- Article
Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison.
- Published in:
- Schizophrenia Research & Treatment, 2014, p. 1, doi. 10.1155/2014/758212
- By:
- Publication type:
- Article
The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial.
- Published in:
- BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-320
- By:
- Publication type:
- Article
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-143
- By:
- Publication type:
- Article
Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2013, v. 9, p. 815, doi. 10.2147/NDT.S43574
- By:
- Publication type:
- Article
Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial.
- Published in:
- BMC Medical Research Methodology, 2012, v. 12, n. 1, p. 142, doi. 10.1186/1471-2288-12-142
- By:
- Publication type:
- Article
Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.
- Published in:
- BMC Psychiatry, 2012, v. 12, n. 1, p. 222, doi. 10.1186/1471-244X-12-222
- By:
- Publication type:
- Article
Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2012, v. 8, p. 113, doi. 10.2147/NDT.S30268
- By:
- Publication type:
- Article
Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.
- Published in:
- Patient Preference & Adherence, 2012, v. 6, p. 521, doi. 10.2147/PPA.S25635
- By:
- Publication type:
- Article
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2011, v. 11, n. 1, p. 23, doi. 10.1186/1471-244X-11-23
- By:
- Publication type:
- Article
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2010, v. 35, n. 2, p. 581, doi. 10.1038/npp.2009.164
- By:
- Publication type:
- Article
Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia.
- Published in:
- BMC Psychiatry, 2010, v. 10, p. 11, doi. 10.1186/1471-244X-10-11
- By:
- Publication type:
- Article
Predictors of switching antipsychotic medications in the treatment of schizophrenia.
- Published in:
- BMC Psychiatry, 2010, v. 10, p. 75, doi. 10.1186/1471-244X-10-75
- By:
- Publication type:
- Article
Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis.
- Published in:
- BMC Psychiatry, 2009, v. 9, p. 1, doi. 10.1186/1471-244X-9-12
- By:
- Publication type:
- Article
Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2008, v. 34, n. 6, p. 1163, doi. 10.1093/schbul/sbm134
- By:
- Publication type:
- Article
An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2007, v. 22, n. 7, p. 455, doi. 10.1002/hup.870
- By:
- Publication type:
- Article
Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.
- Published in:
- Journal of Psychopharmacology, 2005, v. 19, n. 6S, p. 110, doi. 10.1177/0269881105058978
- By:
- Publication type:
- Article
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
- Published in:
- BMC Medicine, 2005, v. 3, p. 21, doi. 10.1186/1741-7015-3-21
- By:
- Publication type:
- Article
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2005, v. 5, p. 3, doi. 10.1186/1471-244X-5-3
- By:
- Publication type:
- Article
Longitudinal Effect of Olanzapine on Fasting Serum Lipids: A Randomized, Prospective, 4-Month Study.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1032, n. 1, p. 295, doi. 10.1196/annals.1314.043
- By:
- Publication type:
- Article
Osteopenia Associated with Increased Prolactin and Aging in Psychiatric Patients Treated with Prolactin-Elevating Antipsychotics.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1032, n. 1, p. 297, doi. 10.1196/annals.1314.044
- By:
- Publication type:
- Article
Dose Response and Atypical Antipsychotics in Schizophrenia.
- Published in:
- CNS Drugs, 2004, v. 18, n. 9, p. 597, doi. 10.2165/00023210-200418090-00005
- By:
- Publication type:
- Article
Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.
- Published in:
- 2004
- By:
- Publication type:
- journal article
International Journal of Neuropsychopharmacology Volume 6, Number 2, pp. 97102.
- Published in:
- International Journal of Neuropsychopharmacology, 2003, v. 6, n. 3, p. 313, doi. 10.1017/s1461145703003602
- By:
- Publication type:
- Article
Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2003, v. 6, n. 2, p. 97, doi. 10.1017/s1461145703003389
- By:
- Publication type:
- Article
Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2003, v. 6, n. 2, p. 97, doi. 10.1017/s1461145703003389
- By:
- Publication type:
- Article
Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2003, v. 6, n. 2, p. 97, doi. 10.1017/s1461145703003389
- By:
- Publication type:
- Article
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.
- Published in:
- International Journal of Geriatric Psychiatry, 2001, v. 16, p. S33, doi. 10.1002/1099-1166(200112)16:1+<::AID-GPS571>3.0.CO;2-5
- By:
- Publication type:
- Article
Update on the Clinical Efficacy and Side Effects of Clozapine.
- Published in:
- Schizophrenia Bulletin, 1991, v. 17, n. 2, p. 247
- By:
- Publication type:
- Article
Dopaminergic Mechanisms in Idiopathic and Drug-Induced Psychoses.
- Published in:
- Schizophrenia Bulletin, 1990, v. 16, n. 1, p. 97, doi. 10.1093/schbul/16.1.97
- By:
- Publication type:
- Article
Tardive dyskinesias and drugs.
- Published in:
- Drug Development Research, 1986, v. 9, n. 1, p. 41, doi. 10.1002/ddr.430090106
- By:
- Publication type:
- Article